<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01939743</url>
  </required_header>
  <id_info>
    <org_study_id>11GS009SUR</org_study_id>
    <nct_id>NCT01939743</nct_id>
  </id_info>
  <brief_title>Efficacy of Diclofenac Suppository for Pain Control in Ultrasound Guided Biopsy of Prostate</brief_title>
  <official_title>Diclofenac Suppository As a Preemptive Analgesia in Ultrasound Guided Biopsy of Prostate: Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aga Khan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aga Khan University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Transrectal ultrasound guided biopsy of prostate (TRUS-Bx) is widely used as accepted mode of
      investigation for prostate cancer in current urology practice. It is considered a minor
      procedure, which most of the patients tolerate, however 20% of patients refuse to undergo the
      redo procedure without any analgesia or anesthesia but on the other hand, some authors reveal
      that 65 to 90% of patients report pain ranging from mild to severe in intensity. Diclofenac
      is a local and systemic anti-inflammatory drug and it reduces local mediators involved in
      local pain.The purpose of this study is to find out the role of rectal administration of
      diclofenac suppositories as an adjunct to 2% xylocaine gel in alleviating intra and post
      procedural pain in prostatic biopsy with adequately calculated sample size and excluding the
      patients with contraindication to procedure or diclofenac administration as these were the
      shortcomings of previous studies.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain on visual analog score</measure>
    <time_frame>Two hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse effects of diclofenac suppository</measure>
    <time_frame>two hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Carcinoma Prostate</condition>
  <arm_group>
    <arm_group_label>diclofenac suppository plus lidocaine gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention Drug with local anaesthetic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lidocaine gel only</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Used as local aneaethetic as a part of institutional prostate biopsy protocol</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Diclofenac suppository plus lidocaine gel</intervention_name>
    <arm_group_label>diclofenac suppository plus lidocaine gel</arm_group_label>
    <other_name>Voltral suppository</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine gel only</intervention_name>
    <arm_group_label>diclofenac suppository plus lidocaine gel</arm_group_label>
    <arm_group_label>Lidocaine gel only</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:All male patients undergoing ultrasound guided prostate biopsy due to
        any one of the following:

          -  Raised prostate-specific antigen level (&gt;4.0ng/ml) and palpable nodularity on digital
             rectal examination

          -  Palpable nodularity on digital rectal examination

          -  Hypo echoic lesion as compared to surrounding prostate on transrectal ultrasound

        Exclusion Criteria:

          -  History of previous prostate biopsy

          -  Acute and/or chronic prostatitis or chronic pelvic pain syndrome

          -  Anal fissure, hemorrhoids, anal surgery

          -  Concomitant analgesic medication

          -  Chronic renal failure

          -  Allergy to diclofenac
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>51 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Naveed Haroon, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aga Khan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aga Khan University Hospital</name>
      <address>
        <city>Karachi</city>
        <state>Sindh</state>
        <zip>3500</zip>
        <country>Pakistan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Pakistan</country>
  </location_countries>
  <reference>
    <citation>Irer B, Gulcu A, Aslan G, Goktay Y, Celebi I. Diclofenac suppository administration in conjunction with lidocaine gel during transrectal ultrasound-guided prostate biopsy: prospective, randomized, placebo-controlled study. Urology. 2005 Oct;66(4):799-802.</citation>
    <PMID>16230141</PMID>
  </reference>
  <reference>
    <citation>Haq A, Patel HR, Habib MR, Donaldson PJ, Parry JR. Diclofenac suppository analgesia for transrectal ultrasound guided biopsies of the prostate: a double-blind, randomized controlled trial. J Urol. 2004 Apr;171(4):1489-91.</citation>
    <PMID>15017205</PMID>
  </reference>
  <verification_date>September 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 1, 2013</study_first_submitted>
  <study_first_submitted_qc>September 7, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 11, 2013</study_first_posted>
  <last_update_submitted>September 7, 2013</last_update_submitted>
  <last_update_submitted_qc>September 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aga Khan University</investigator_affiliation>
    <investigator_full_name>Naveed Haroon</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prostatic Neoplasms</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
    <mesh_term>Diclofenac</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

